ArticleFrontiers in oncology2023

Low neutrophil-to-lymphocyte ratio predicts overall survival benefit in advanced NSCLC patients with low PD-L1 expression and receiving chemoimmunotherapy.

Chian-Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.